Cover Image
Market Research Report

Global Molecular Biology Enzymes, Kits, and Reagents Market 2019-2023

Published by TechNavio (Infiniti Research Ltd.) Product code 823161
Published Content info 121 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Molecular Biology Enzymes, Kits, and Reagents Market 2019-2023
Published: March 29, 2019 Content info: 121 Pages
Description

About this market

The rising incidence of infectious diseases and genetic disorders will drive the market growth in the forecast period. Incidences of infections caused by pathogens including bacteria, fungi, viruses, and parasites are likely to contribute to the surging incidences of bladder infections and urinary tract infections. In addition, researchers are increasingly focusing on molecular biology for treating diseases using gene therapy and recombinant vaccines. This will further lead the molecular biology enzymes, kits, and reagents market growth during the forecast period. Technavio's analysts have predicted that the molecular biology enzymes, kits, and reagents market will register a CAGR of 16% by 2023.

Market Overview

Increased use of proteins and reagents in biotechnology and pharmaceutical companies

One of the growth drivers of the global molecular biology enzymes, kits, and reagents market is the increased use of proteins and reagents in biotechnology and pharmaceutical companies. The increased use of proteins and reagents in biotechnology and pharmaceutical companies for applications such as drug discovery and development and in molecular biology research has propelled the growth of the market.

High costs and lack of reimbursement policies for genetic testing

One of the challenges in the growth of the global molecular biology enzymes, kits, and reagents market is the high costs and lack of reimbursement policies for genetic testing. The expensive nature of genetic tests leads to their decreased adoption among individuals, thereby reducing the overall demand for molecular biology enzymes, kits, and reagents necessary to perform these tests.

For the detailed list of factors that will drive and challenge the growth of the molecular biology enzymes, kits, and reagents market during 2019-2023, view our report.

Competitive Landscape

The market appears to be moderately fragmented with the presence of several market players. Vendors in the market are focusing on offering a portfolio of diagnostic assays to hospitals, community clinics, pathology laboratories, and immunology laboratories for diagnosis of patients, pathogen detection, and viral load monitoring. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

Table of Contents
Product Code: IRTNTR31035

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Biotechnology and pharmaceutical companies - Market size and forecast 2018-2023
  • Hospitals and diagnostic centers - Market size and forecast 2018-2023
  • Academic institutes and research organizations - Market size and forecast 2018-2023
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Rising use of molecular biology kits for disease diagnosis
  • Increasing number of applications of molecular biology
  • enzymes, kits, and reagents
  • Technological advances in the life sciences industry

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • Merck KGaA
  • Thermo Fisher Scientific Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations

PART 15: EXPLORE TECHNAVIO

List of Exhibits

  • Exhibit 01: Global healthcare market
  • Exhibit 02: Segments of global healthcare market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2018
  • Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 09: Five forces analysis 2018
  • Exhibit 10: Five forces analysis 2023
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2018
  • Exhibit 17: End-user - Market share 2018-2023 (%)
  • Exhibit 18: Comparison by end-user
  • Exhibit 19: Biotechnology and pharmaceutical companies - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 20: Biotechnology and pharmaceutical companies - Year-over-year growth 2019-2023 (%)
  • Exhibit 21: Hospitals and diagnostic centers - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 22: Hospitals and diagnostic centers - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: Academic institutes and research organizations - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 24: Academic institutes and research organizations - Year-over-year growth 2019-2023 (%)
  • Exhibit 25: Market opportunity by end-user
  • Exhibit 26: Customer landscape
  • Exhibit 27: Market share by geography 2018-2023 (%)
  • Exhibit 28: Geographic comparison
  • Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 32: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 36: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 37: Key leading countries
  • Exhibit 38: Market opportunity
  • Exhibit 39: Impact of drivers and challenges
  • Exhibit 40: Vendor landscape
  • Exhibit 41: Landscape disruption
  • Exhibit 42: Vendors covered
  • Exhibit 43: Vendor classification
  • Exhibit 44: Market positioning of vendors
  • Exhibit 45: Agilent Technologies, Inc. - Vendor overview
  • Exhibit 46: Agilent Technologies, Inc. - Business segments
  • Exhibit 47: Agilent Technologies, Inc. - Organizational developments
  • Exhibit 48: Agilent Technologies, Inc. - Geographic focus
  • Exhibit 49: Agilent Technologies, Inc. - Segment focus
  • Exhibit 50: Agilent Technologies, Inc. - Key offerings
  • Exhibit 51: F. Hoffmann-La Roche Ltd - Vendor overview
  • Exhibit 52: F. Hoffmann-La Roche Ltd - Business segments
  • Exhibit 53: F. Hoffmann-La Roche Ltd - Organizational developments
  • Exhibit 54: F. Hoffmann-La Roche Ltd - Geographic focus
  • Exhibit 55: F. Hoffmann-La Roche Ltd - Segment focus
  • Exhibit 56: F. Hoffmann-La Roche Ltd - Key offerings
  • Exhibit 57: Illumina, Inc. - Vendor overview
  • Exhibit 58: Illumina, Inc. - Product segments
  • Exhibit 59: Illumina, Inc. - Organizational developments
  • Exhibit 60: Illumina, Inc. - Geographic focus
  • Exhibit 61: Illumina, Inc. - Segment focus
  • Exhibit 62: Illumina, Inc. - Key offerings
  • Exhibit 63: Merck KGaA - Vendor overview
  • Exhibit 64: Merck KGaA - Business segments
  • Exhibit 65: Merck KGaA - Organizational developments
  • Exhibit 66: Merck KGaA - Geographic focus
  • Exhibit 67: Merck KGaA - Segment focus
  • Exhibit 68: Merck KGaA - Key offerings
  • Exhibit 69: Thermo Fisher Scientific Inc. - Vendor overview
  • Exhibit 70: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 71: Thermo Fisher Scientific Inc. - Organizational developments
  • Exhibit 72: Thermo Fisher Scientific Inc. - Geographic focus
  • Exhibit 73: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibit 74: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 75: Validation techniques employed for market sizing
Back to Top